{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:06:11Z","timestamp":1765976771763,"version":"3.40.5"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The goal of this study was to evaluate the relationship between serum lipoprotein(a) [Lp(a)] levels and diabetic nephropathy (DN) among Han Chinese individuals with type 2 diabetes mellitus (T2DM). This retrospective analysis comprised a consecutive case series of 767 grown-up patients with T2DM (199 among them with DN) hospitalized in the Department of Endocrinology at the The First Affiliated Hospital of Anhui Medical University from February 20220 to February 2021. Clinical data and other laboratory measurements, such as glycated hemoglobin (HbA1c), were extracted from medical records and compared among groups. Clinical characteristics according to Lp(a) quartiles were also studied. Univariate and multivariate regression analysis were used to examine the relationship between serum Lp(a) and DN. Patients with DN had a longer disease duration, higher HbA1c, higher level of Lp(a), and were more likely to have diabetic retinopathy (DR) than those without DN (P &lt; 0.005 for each). With regard to the Lp(a) quartile group, patients with a higher Lp(a) concentration were more likely to have DN and have higher level of HbA1c during the study (P for trend &lt; 0.005 for each). After adjusting for several confounding factors, the development of DN was significantly associated with the serum Lp(a) level (P = 0.026, comparing the 4th vs 1st quartile of Lp(a)) according to multivariate regression analysis. The receiver operating characteristic (ROC) curves for DN development using serum Lp(a) showed that the area under the receiver operating characteristic curves (AUC) was 0.590 (P &lt; 0.001). Findings from this study demonstrated that the DN was independently associated with the serum Lp(a) level in patients with T2DM in this retrospective study.<\/jats:p>","DOI":"10.1371\/journal.pone.0299240","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:38:35Z","timestamp":1715708315000},"page":"e0299240","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between lipoprotein(a) plasma levels and diabetic nephropathy in Han Chinese patients with type 2 diabetes mellitus"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4857-3871","authenticated-orcid":true,"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"issue":"1","key":"pone.0299240.ref001","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-018-4816-5","article-title":"Engrailed-2 (EN2)\u2014a novel biomarker in epithelial ovarian cancer","volume":"18","author":"SE McGrath","year":"2018","journal-title":"BMC Cancer"},{"issue":"4","key":"pone.0299240.ref002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/jdi.13371","article-title":"Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study","volume":"12","author":"L Liu","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"5","key":"pone.0299240.ref003","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","article-title":"Human plasma fibrinogen is synthesized in the liver","volume":"109","author":"GA Tennent","year":"2007","journal-title":"Blood"},{"key":"pone.0299240.ref004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"JW Weisel","year":"2005","journal-title":"Adv Protein Chem"},{"key":"pone.0299240.ref005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijnurstu.2018.01.009","article-title":"The effectiveness of traditional Chinese medicine-based lifestyle interventions on biomedical, psychosocial, and behavioral outcomes in individuals with type 2 diabetes: A systematic review with meta-analysis","volume":"80","author":"X Yu","year":"2018","journal-title":"Int J Nurs Stud"},{"issue":"5","key":"pone.0299240.ref006","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40620-020-00739-8","article-title":"Atherogenic dyslipidemia and diabetic nephropathy","volume":"33","author":"G Russo","year":"2020","journal-title":"J Nephrol"},{"issue":"5","key":"pone.0299240.ref007","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/jdi.13257","article-title":"Protective factors as biomarkers and targets for prevention and treatment of diabetic nephropathy: From current human evidence to future possibilities","volume":"11","author":"N. Nowak","year":"2020","journal-title":"J Diabetes Investig"},{"issue":"1","key":"pone.0299240.ref008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"F Kronenberg","year":"2013","journal-title":"J Intern Med"},{"issue":"6","key":"pone.0299240.ref009","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1463-1326.2007.00670.x","article-title":"Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications","volume":"9","author":"AJ Krentz","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"pone.0299240.ref010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jdiacomp.2016.02.006","article-title":"Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus","volume":"30","author":"H Senba","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"6","key":"pone.0299240.ref011","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00125-020-05120-9","article-title":"Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus","volume":"63","author":"SS Singh","year":"2020","journal-title":"Diabetologia"},{"issue":"9","key":"pone.0299240.ref012","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Global Diabetic Retinopathy Project Group","year":"2003","journal-title":"Ophthalmology"},{"issue":"5","key":"pone.0299240.ref013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/dme.12862","article-title":"Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus","volume":"33","author":"JS Yun","year":"2016","journal-title":"Diabet Med"},{"issue":"10","key":"pone.0299240.ref014","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.numecd.2020.05.011","article-title":"Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study","volume":"30","author":"F Moosaie","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"pone.0299240.ref015","first-page":"93","article-title":"Relationship between lipoprotein (a) and micro\/macro complications in type 2 diabetes mellitus: a forgotten target","volume":"12","author":"R Toro","year":"2015","journal-title":"J Geriatr Cardiol"},{"issue":"12","key":"pone.0299240.ref016","doi-asserted-by":"crossref","first-page":"e114397","DOI":"10.1371\/journal.pone.0114397","article-title":"Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria","volume":"9","author":"J Lin","year":"2014","journal-title":"PLoS One"},{"key":"pone.0299240.ref017","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2018.12.022","article-title":"Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study","volume":"282","author":"A Saeed","year":"2019","journal-title":"Atherosclerosis"},{"issue":"7","key":"pone.0299240.ref018","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/dc19-0274","article-title":"Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes","volume":"42","author":"JL Jin","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"pone.0299240.ref019","doi-asserted-by":"crossref","first-page":"107593","DOI":"10.1016\/j.jdiacomp.2020.107593","article-title":"Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuria","volume":"34","author":"NS Heinrich","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"7","key":"pone.0299240.ref020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1194\/jlr.R051904","article-title":"Lipoprotein (a): impact by ethnicity and environmental and medical conditions","volume":"57","author":"B Enkhmaa","year":"2016","journal-title":"J Lipid Res"},{"issue":"4932","key":"pone.0299240.ref021","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein(a)","volume":"246","author":"G. Utermann","year":"1989","journal-title":"Science"},{"issue":"12","key":"pone.0299240.ref022","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.ATV.0000144010.55563.63","article-title":"Lipoprotein(a): an elusive cardiovascular risk factor","volume":"24","author":"L Berglund","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"pone.0299240.ref023","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/ajkd.2002.36319","article-title":"Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991\u20131994)","volume":"40","author":"CP Kovesdy","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"pone.0299240.ref024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"125","author":"SS Virani","year":"2012","journal-title":"Circulation"},{"key":"pone.0299240.ref025","doi-asserted-by":"crossref","first-page":"291954","DOI":"10.1155\/2011\/291954","article-title":"Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients","volume":"2011","author":"D Banerjee","year":"2011","journal-title":"J Lipids"},{"issue":"3","key":"pone.0299240.ref026","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MOL.0000000000000753","article-title":"The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk","volume":"32","author":"G. Reyes-Soffer","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"pone.0299240.ref027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2022.04.005","article-title":"Lipoprotein(a) and ethnicities","volume":"349","author":"A Mehta","year":"2022","journal-title":"Atherosclerosis"},{"issue":"4","key":"pone.0299240.ref028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1194\/jlr.R083626","article-title":"The role of lipoprotein (a) in chronic kidney disease","volume":"59","author":"JC Hopewell","year":"2018","journal-title":"J Lipid Res"},{"issue":"1","key":"pone.0299240.ref029","doi-asserted-by":"crossref","first-page":"108378","DOI":"10.1016\/j.jdiacomp.2022.108378","article-title":"Study on the relationship between lipoprotein (a) and diabetic kidney disease","volume":"37","author":"A Wang","year":"2023","journal-title":"J Diabetes Complications"},{"issue":"3","key":"pone.0299240.ref030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000112225","article-title":"Effects of renal replacement therapy on plasma lipoprotein(a) levels","volume":"28","author":"S Rosas","year":"2008","journal-title":"Am J Nephrol"},{"key":"pone.0299240.ref031","doi-asserted-by":"crossref","first-page":"1023919","DOI":"10.3389\/fendo.2022.1023919","article-title":"Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses","volume":"13","author":"Y Xie","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0299240.ref032","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12882-023-03417-6","article-title":"Association between serum lipoprotein(a) and mildly reduced eGFR: a cross-sectional study","volume":"24","author":"H Zhang","year":"2023","journal-title":"BMC Nephrol"},{"issue":"4","key":"pone.0299240.ref033","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2362.1996.132283.x","article-title":"Hyperlipoprotein(a)aemia in nephrotic syndrome","volume":"26","author":"J Thiery","year":"1996","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"pone.0299240.ref034","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.V981474","article-title":"Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome","volume":"9","author":"Der Velden MG De Sain-Van","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"pone.0299240.ref035","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s40620-023-01590-3","article-title":"Relationship between lipoprotein(a) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies","volume":"36","author":"L Barbagelata","year":"2023","journal-title":"J Nephrol"},{"issue":"2\u20133","key":"pone.0299240.ref036","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1900\/RDS.2013.10.110","article-title":"Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials","volume":"10","author":"CC Hung","year":"2013","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"pone.0299240.ref037","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(99)00064-7","article-title":"Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux","volume":"143","author":"LB Nielsen","year":"1999","journal-title":"Atherosclerosis"},{"issue":"7","key":"pone.0299240.ref038","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ndt\/12.7.1330","article-title":"Lipoprotein(a) induces glomerular superoxide anion production","volume":"12","author":"S Greiber","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"pone.0299240.ref039","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.1999.00351.x","article-title":"Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress","volume":"55","author":"J Galle","year":"1999","journal-title":"Kidney Int"},{"issue":"3","key":"pone.0299240.ref040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1096\/fj.05-4857fje","article-title":"Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin","volume":"20","author":"SN Sotiriou","year":"2006","journal-title":"FASEB J"},{"issue":"7","key":"pone.0299240.ref041","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/jcm12072529","article-title":"Lipoprotein (a), Inflammation, and Atherosclerosis","volume":"12","author":"SA Di Fusco","year":"2023","journal-title":"J Clin Med"},{"key":"pone.0299240.ref042","first-page":"w20139","article-title":"Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus","volume":"149","author":"MZ Kocak","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"12","key":"pone.0299240.ref043","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3390\/diagnostics13122063","article-title":"Could Systemic Inflammatory Index Predict Diabetic Kidney Injury in Type 2 Diabetes Mellitus?","volume":"13","author":"T Taslamacioglu Duman","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"pone.0299240.ref044","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/00325481.2023.2214058","article-title":"Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury?","volume":"135","author":"G Aktas","year":"2023","journal-title":"Postgrad Med"},{"issue":"6","key":"pone.0299240.ref045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pcd.2021.08.015","article-title":"Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study","volume":"15","author":"S Bilgin","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"pone.0299240.ref046","doi-asserted-by":"crossref","first-page":"885516","DOI":"10.3389\/fendo.2022.885516","article-title":"Association Between High-Sensitivity C-Reactive Protein and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus","volume":"13","author":"M Tang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"pone.0299240.ref047","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jacl.2015.12.030","article-title":"Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus","volume":"10","author":"JS Yun","year":"2016","journal-title":"J Clin Lipidol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0299240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:39:00Z","timestamp":1715708340000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0299240"}},"subtitle":[],"editor":[{"given":"Luiz S\u00e9rgio Fernandes","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0299240","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,5,14]]}}}